Veterinary Medicines

Advantage 400 mg Lösung zum Auftropfen auf die Haut für Hunde

Authorised
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
Advantage 400 mg Lösung zum Auftropfen auf die Haut für Hunde
Advantage 400 soluzione spot-on per cani
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    400.00
    milligram(s)
    /
    4.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Pack sizes 4.0 ml solution per pipette, Pack containing 1 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 4.0 ml solution per pipette, Pack containing 2 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 4.0 ml solution per pipette, Pack containing 3 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 4.0 ml solution per pipette, Pack containing 4 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 4.0 ml solution per pipette, Pack containing 6 unit dose pipettes, Container: White polypropylene pipettes with caps

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco Italia S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 102396
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0020/004
Concerned member states:
  • Denmark
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 11/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."